In Brief: Medtronic Reveal
This article was originally published in The Gray Sheet
Executive Summary
Medtronic Reveal: Insertable loop recorder (ILR) launches in Europe and Canada for long-term monitoring and recording of electrical activity of the heart that may suggest cardiac arrhythmia. Placed in the chest region under a patient's skin, the 2.5 x 3/4 inch device features sensors that continuously record electrocardiogram signals. The system can be programmed to record and store up to 42 minutes of ECG data and lasts about 14 months, Medtronic says. Activation of an external, hand-held component preserves ECG data recorded during transient cardiac events. U.S. launch is slated for early 1998...
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.